SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,669,386 | +77.0% | 1,392,356 | +109.5% | 0.01% | +66.7% |
Q1 2023 | $3,769,042 | +0.7% | 664,734 | -0.6% | 0.00% | -25.0% |
Q4 2022 | $3,743,270 | +142.6% | 668,441 | +218.0% | 0.00% | +100.0% |
Q1 2018 | $1,543,000 | -33.1% | 210,198 | -7.6% | 0.00% | 0.0% |
Q4 2017 | $2,308,000 | -88.2% | 227,586 | -66.1% | 0.00% | -90.5% |
Q2 2016 | $19,482,000 | +82.8% | 670,639 | +67.1% | 0.02% | +90.9% |
Q1 2016 | $10,657,000 | -23.9% | 401,257 | +0.6% | 0.01% | -21.4% |
Q4 2015 | $13,999,000 | +20.6% | 398,959 | +1.9% | 0.01% | +16.7% |
Q3 2015 | $11,610,000 | -28.3% | 391,700 | +0.4% | 0.01% | -20.0% |
Q2 2015 | $16,185,000 | – | 390,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
Geduld E E | 15,000 | $149,000 | 0.08% |
Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |